FDA Cites Celgene For Tardy Adverse Event Reporting On Thalomid

Celgene has hired a new contractor to process adverse event reports for thalidomide, although the agency says it will have to “assess the adequacy of the correction during a future inspection.” An FDA letter cites 82 instances of delayed reports.